| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $128.4M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2019 | OCUL Ocular Therapeutix, Inc | 10% Owner | Buy | 20,000 | $3.97 | $79,410.00 | +0.4% | |
| Mar 11, 2016 | HROW Harrow, Inc. | 10% Owner | Buy | 45,000 | $3.65 | $164,250.00 | +3.7% | |
| Jun 30, 2015 | HROW Harrow, Inc. | 10% Owner | Buy | 35,000 | $7.90 | $276,500.00 | +3.0% | |
| May 19, 2015 | HROW Harrow, Inc. | 10% Owner | Buy | 2,801 | $8.00 | $22,408.00 | +0.2% |